Publications by authors named "Marc Spielmann"

Claim this Profile
R
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Joseph Gligorov, Marc-Antoine Benderra, Xavier Barthere, Louise de Forceville, Eric Charles Antoine, Marc Spielmann

Bull Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)].
Joseph Gligorov, Thomas Bachelot, Jean-Yves Pierga, Eric-Charles Antoine, Corinne Balleyguier, Marc Spielmann

Bull Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
Barbara Pistilli, Chafika Mazouni, Anna Zingarello, Matthieu Faron, Mahasti Saghatchian, Marc Spielmann

Clin Breast Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Pascal Pujol, Pierre Vande Perre, Laurence Faivre, Damien Sanlaville, Carole Corsini, Marc Spielmann

Eur J Hum Genet· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer.
Mario Campone, Magali Lacroix-Triki, Lise Roca, Marc Spielmann, Hans Wildiers

Eur J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.
Sylvain Ladoire, Frédérique Penault-Llorca, Laura Senovilla, Cécile Dalban, David Enot, Marc Spielmann

Autophagy· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
Séverine Guiu, Céline Charon-Barra, Déwi Vernerey, Pierre Fumoleau, Mario Campone, Marc Spielmann

Future Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Perception of pT1a,b pN0 breast tumor prognosis by the French oncology community: Results of the EURISTIC national survey].
Marc Spielmann, Florence Dalenc, Yoann Pointreau, David Azria, Jean-Marc Classe

Bull Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relations between arthralgia and fear of recurrence: results of a cross-sectional study of breast cancer patients treated with adjuvant aromatase inhibitors therapy.
Clémentine Lopez, Cécile Charles, Pascal Rouby, Diane Boinon, Sophie Laurent, Marc Spielmann

Support Care Cancer· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials.
Ciara C O'Sullivan, Ian Bradbury, Christine Campbell, Marc Spielmann, Edith A Perez

J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer.
Yasser Abdel Kader, Marc Spielmann, Tamer El-Nahas, Amr Sakr, Hassan Metwally

Breast Cancer (Dove Med Press)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials.
Sylvain Ladoire, Cecile Dalban, Henri Roché, Marc Spielmann, Pierre Fumoleau

Eur J Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors of young women (≤ 35 years) with node positive breast cancer: possible influence on post-therapeutic follow-up.
Thomas Filleron, Florence Dalenc Md, Andrew Kramar, Marc Spielmann, Christelle Levy

Bull Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Lise Roca, Véronique Diéras, Henri Roché, Emmanuelle Lappartient, Pierre Kerbrat, Marc Spielmann

Breast Cancer Res Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
Bruno Coudert, Bernard Asselain, Mario Campone, Marc Spielmann, Jean-Pascal Machiels

Oncologist· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up.
Thomas Filleron, Andrew Kramar, Florence Dalenc, Marc Spielmann, Pierre Fumoleau

Bull Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation.
Fares Azoury, Steve Heymann, Catalina Acevedo, Marc Spielmann, Philippe Vielh

Radiother Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.
Elisabeth Luporsi, Fabrice André, Frédérique Spyratos, Pierre-Marie Martin, Jocelyne Jacquemier, Marc Spielmann

Breast Cancer Res Treat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exclusive alternating chemotherapy and radiotherapy in nonmetastatic inflammatory breast cancer: 20 years of follow-up.
Céline Bourgier, Eduardo Lima Pessoa, Ariane Dunant, Steve Heymann, Marc Spielmann

Int J Radiat Oncol Biol Phys· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study.
Marc Spielmann, Elisabeth Luporsi, Isabelle Ray-Coquard, Stéphane de Botton, David Azria

Eur J Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Node negative breast cancer. Beyond international consensus: a pragmatic approach].
Frédérique Penault-Llorca, David Coeffic, Thierry Delozier, Nadine Dohollou, Gilles Freyer, Marc Spielmann

Bull Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcoma.
Olivier Mir, Julien Domont, Angela Cioffi, Sylvie Bonvalot, Bérénice Boulet, Marc Spielmann

Eur J Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Jean-Marc Extra, Eric C Antoine, Anne Vincent-Salomon, Thierry Delozier, Pierre Kerbrat, Marc Spielmann

Oncologist· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
Jean-Yves Pierga, Suzette Delaloge, Marc Espié, Etienne Brain, Brigitte Sigal-Zafrani, Marc Spielmann

Breast Cancer Res Treat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D-conformal accelerated partial breast irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity.
Maia Dzhugashvili, Elodie Tournay, Charlotte Pichenot, Ariane Dunant, Eduardo Pessoa, Marc Spielmann

Radiat Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis